mechanism 1,931 words KG: CR3
Contents

CR3-Dependent Microglial Synapse Elimination in Parkinson's Disease

Mechanism Info
NameCR3
Key Genes/ProteinsC1Q, C3, CD33, CD47, Complement C3, CX3CR1
Related DiseasesAlzheimer's disease, Alzheimer's Disease
Related Pathwayscomplement cascade, ferroptosis
Linked Hypotheses2 hypotheses

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (32)

Competitive APOE4 Domain Stabilization Peptides
Score: 0.78
Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.72
SASP-Mediated Cholinergic Synapse Disruption
Score: 0.76
APOE Isoform Expression Across Glial Subtypes
Score: 0.74
Near-infrared light therapy stimulates COX4-dependent mitoch
Score: 0.74
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.74
APOE Isoform Conversion Therapy
Score: 0.72
Complement C1QA Spatial Gradient in Cortical Layers
Score: 0.68
RAB27A-dependent extracellular vesicle engineering for mitoc
Score: 0.67
Optogenetic Microglial Deactivation via Engineered Inhibitor
Score: 0.66
LRP1-Dependent Tau Uptake Disruption
Score: 0.60
TREM2-Mediated Selective Aggregate Clearance Pathway
Score: 0.58
← Prevpg 2/2

Related Analyses (30)

Neuroinflammation and microglial priming in early Alzheimer'
neurodegeneration · archived
SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived

Related Experiments (30)

LPS-induced mouse model of depression with synaptic loss ana
validation · proposed · Score: 0.90
C1q neutralizing antibody intervention in depression model
validation · proposed · Score: 0.85
TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.45
Alpha-Synuclein SAA Kinetics Study — Biological Staging Back
clinical · proposed · Score: 0.40
Antiviral Therapy Trial for Parkinson's Disease
clinical · proposed · Score: 0.40

See Also (4)

C1QA Gene — Complement Component 1q A Chain
gene · KG edge: interacts_with
C3 — Complement Component 3
gene · KG edge: interacts_with
TYROBP — TYRO Binding Protein (DAP12)
gene · KG edge: interacts_with
Microglial Phagocytosis in Neurodegeneration
mechanism · KG edge: mediates

Knowledge Graph (12 edges)

C3 interacts_with CR3
TYROBP interacts_with CR3
CR3 involved_in Synaptic Pruning
CR3 regulates Phagocytic Microglia
Complement C3 binds CR3
CR3 mediates Synaptic Pruning
C1Q interacts_with CR3
C1Q signals_through CR3
CR3 mediates microglial phagocytosis of synapses
CR3 involved_in Synapse Loss

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.